The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
- 1 January 2012
- journal article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 8 (4), 451-458
- https://doi.org/10.7150/ijbs.4038
Abstract
To evaluate the promoter methylation status of RECK gene and mRNA expression in patients with hepatocellular carcinoma (HCC). We analyzed RECK methylation by MSP, and RECK mRNA by real-time PCR in 74 HCC. The liver cell lines (7721, Chang and Hep-G2) were treated with 5-Aza-CdR and TSA. RECK mRNA were lower in HCC tissues (Mean (-∆Ct) = -3.29) than that in Non-Hcc tissues (Mean (-∆Ct) = -2.42). Expression of RECK was elevated in only 24 (32.43%) of the 74 HCC patients but decreased (-∆∆Ct=0.5) (Mean (-∆∆Ct) = -1.75) than those with demethylation (∆MI<0.5) (Mean (-∆∆Ct) = 0.05), and there is a decreased tendency for RECK mRNA in HCC patients with promoter hypermethylation (p = 0.002). There was a significantly correlation found between RECK mRNA and poor survival after surgery. After treated by 5-Aza-CdR and TSA, we found that RECK mRNA induced different changes in 7721, Chang and Hep-G2 cells. And RECK demethylation also induced by epigenetic inhibitors. The results suggested that the hypermethylation may lead to promoter silencing of RECK mRNA and associated with poor survival in HCC.Keywords
This publication has 24 references indexed in Scilit:
- Cancer epigenetics reaches mainstream oncologyNature Medicine, 2011
- Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastasesThe Esophagus, 2010
- What We Learn From Transformation Suppressor Genes: Lessons From RECKFuture Oncology, 2010
- RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancerCancer and Metastasis Reviews, 2007
- Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinomaWorld Journal of Gastroenterology, 2007
- Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancerCancer Letters, 2006
- Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancerEuropean Journal of Cancer, 2006
- Prognostic Significance of Reversion-Inducing Cysteine-Rich Protein With Kazal Motifs Expression in Resected Pathologic Stage IIIA N2 Non–Small-Cell Lung CancerAnnals of Surgical Oncology, 2005
- Matrix metalloproteinase inhibitor reversion‐inducing cysteine‐rich protein with Kazal motifsCancer, 2003
- RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.2003